Latest Breaking News On - Capsida therapeutics - Page 1 : comparemela.com

AbbVie and Capsida Therapeutics are expanding their gene therapy R&D alliance to the eyes. Capsida is in line to receive $70 million now and up to $595 million later, depending on the progress of the eye programs.

Peter anastasiouEli lillyCapsida biotherapeuticsVertex pharmaceuticalsNorth chicago basedCalifornia based capsidaSarepta therapeuticsAffinia therapeuticsWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock health